{"nct_id":"NCT04735432","title":"Evaluating the Pharmacodynamic Noninferiority of Efgartigimod PH20 SC Administered Subcutaneously as Compared to Efgartigimod Administered Intravenously in Patients With Generalized Myasthenia Gravis","status":"COMPLETED","status_verified_date":"2023-01","start_date":"2021-02-05","start_date_type":"ACTUAL","primary_completion_date":"2021-11-02","primary_completion_date_type":"ACTUAL","completion_date":"2021-12-13","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ARGX"]}